Zephyrm Bioscience, a Chinese stem-cell drug developer, is seeking an IPO on the Hong Kong Stock Exchange amidst a surge in losses and a buoyant market. The company, known for its innovative cell therapy products, is hoping to raise funds to support its R&D efforts and upcoming commercialization, but its financial performance raises concerns.
A new study using miniature brain models grown from the stem cells of toddlers with autism has uncovered a potential link between the severity of autism symptoms and accelerated brain growth during early development. The study, published in the journal ‘Nature,’ found that brain organoids from toddlers with autism grew significantly faster than those from toddlers without the disorder, and this excessive growth was associated with more severe social symptoms. The research also identified a gene, Ndel1, that may play a role in this accelerated growth.
Scientists have created miniature models of the human brain that include the organ’s protective blood-brain barrier (BBB). The models, which are about the size of a sesame seed, could be used to study neurological diseases and develop new treatments.
Exosomes, tiny messengers from stem cells, are revolutionizing skin rejuvenation. From reducing hyperpigmentation to promoting skin’s regenerative processes, exosomes are delivering youthful, radiant results. Delivered topically through microneedling, exosomes penetrate deep into the dermis, stimulating collagen production and improving skin texture. Although exosome therapy can come with a hefty price tag, the long-lasting effects and minimal downtime make it an attractive option for those seeking a youthful glow.
